Rare Dysfunctional Complement Factor I Genetic Variants and Progression to Advanced Age-Related Macular Degeneration

Johanna M Seddon1, Bernard Rosner2, Dikha De1

  • 1Department of Ophthalmology and Visual Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts.

Ophthalmology Science
|March 13, 2023
PubMed

Insights

Rare dysfunctional complement factor I (CFI) variants significantly increase the risk of developing advanced age-related macular degeneration (AMD) with geographic atrophy (GA). This finding highlights CFI's role in AMD progression.

Area of Science:

  • Ophthalmology
  • Genetics
  • Molecular Biology

Background:

  • Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults.
  • Genetic factors play a significant role in AMD pathogenesis.
  • Complement factor I (CFI) is involved in regulating the complement system, a key component of the immune response.

Purpose of the Study:

  • To investigate the association between rare dysfunctional complement factor I (CFI) genetic variants and the progression to advanced AMD, specifically geographic atrophy (GA) and neovascular disease (NV).

Main Methods:

  • A prospective, longitudinal study involving 4953 participants aged 55-80 with non-advanced AMD at baseline.
  • Genotyping and sequencing were used to identify rare CFI variants, categorized as type 1 (associated with low factor I protein levels and function).
  • Generalized estimating equations were employed to assess the association between CFI variants and AMD progression, adjusting for genetic and environmental factors.

Main Results:

  • 1% of participants were identified as type 1 rare CFI carriers.
  • CFI carriers showed a significantly higher progression rate to advanced AMD (44% vs. 20%), GA (30% vs. 10%), and NV (18% vs. 11%) over 12 years compared to non-carriers.
  • CFI carrier status was independently associated with GA progression (OR=1.91) and a higher baseline AMD grade.
  • Higher body mass index (BMI ≥ 25) was associated with increased AMD progression specifically in CFI carriers (OR=5.8).

Conclusions:

  • Carriers of rare dysfunctional type 1 CFI variants face a substantially elevated risk of progressing to advanced AMD with geographic atrophy.
  • These findings underscore the critical role of the complement system, particularly CFI, in AMD development and progression.
  • Elevated BMI may exacerbate AMD progression in individuals with specific CFI genetic profiles.
Abstract

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.2K
Genetic Lingo01:11

Genetic Lingo

Overview
103.5K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.0K